Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNγ-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 225 (1) , 53-63
- https://doi.org/10.1016/j.cellimm.2003.09.002
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Potent activity of soluble B7RP‐1‐Fc in therapy of murine tumors in syngeneic hostsInternational Journal of Cancer, 2002
- Cross-linking the B7 Family Molecule B7-DC Directly Activates Immune Functions of Dendritic CellsThe Journal of Experimental Medicine, 2002
- The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune ResponsesAnnual Review of Immunology, 2002
- Genetic disruption of host interferon-γ drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthaseOncogene, 2001
- LICOS, a primordial costimulatory ligand?Current Biology, 2000
- B7h, a Novel Costimulatory Homolog of B7.1 and B7.2, Is Induced by TNFαImmunity, 1999
- INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative ApproachesAnnual Review of Immunology, 1997
- A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.Proceedings of the National Academy of Sciences, 1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.The Journal of Experimental Medicine, 1977